GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 420 filers reported holding GUARDANT HEALTH INC in Q4 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $327,000 | -34.2% | 4,932 | -0.8% | 0.01% | -28.6% |
| Q4 2021 | $497,000 | -26.3% | 4,970 | -7.8% | 0.01% | -30.0% |
| Q3 2021 | $674,000 | -22.6% | 5,390 | -23.1% | 0.02% | -23.1% |
| Q2 2021 | $871,000 | +37.4% | 7,012 | +68.8% | 0.03% | +30.0% |
| Q1 2021 | $634,000 | -32.6% | 4,153 | -43.1% | 0.02% | -37.5% |
| Q4 2020 | $940,000 | -43.6% | 7,296 | -51.1% | 0.03% | -51.5% |
| Q3 2020 | $1,668,000 | +86.0% | 14,920 | +34.9% | 0.07% | +69.2% |
| Q2 2020 | $897,000 | +19.1% | 11,059 | +2.2% | 0.04% | -13.3% |
| Q1 2020 | $753,000 | +27.6% | 10,826 | +43.5% | 0.04% | +80.0% |
| Q4 2019 | $590,000 | -33.5% | 7,545 | -45.7% | 0.02% | -41.9% |
| Q3 2019 | $887,000 | +17.2% | 13,893 | +58.5% | 0.04% | +10.3% |
| Q2 2019 | $757,000 | +142.6% | 8,768 | +115.5% | 0.04% | +116.7% |
| Q1 2019 | $312,000 | – | 4,068 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
| Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
| Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
| Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
| Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
| Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
| AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
| Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
| STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |